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A question that I like being asked is
“Why have you left biology to go to
business school?” Until recently, my
answer has been a diatribe on the
boredom induced by doing thousands
of plasmid preps and the fickleness of
the funding process. But now, halfway
through a business degree, I have a
much better answer: “Because the
knowledge industry has changed.” As
biology is becoming more like other
businesses, it has become necessary
to acquire some business know-how.
The main occupation of scientists
is the production of units of
knowledge (see Curr Biol 1998,
8:R255). The first stage of this
production process involves deciding
which units their laboratory should
produce. This decision is based on
both the core competencies of the
laboratory and on identifying
unoccupied market niches in which
to sell their units. Once this is done,
the scientist must decide which bits
of data are required to form the
desired knowledge units, produce the
data, process them into information
and interpret the information into
knowledge units. Traditionally, these
units would be sold directly to
scientific journals and conference
organisers and their sale rewarded
with job offers in good institutes and
generous grants.
But the production of knowledge
units is expensive, in terms of both
time and money, and low levels of
productivity often have dire
consequences when it comes to the
next job or grant application. As a
result, many laboratories try to
minimise the effects of competition
through product differentiation. This
has resulted in a highly fractionated
industry that produces unique units
such as ‘The effects of Patagonian
snow-snake venom on stomatal
closure in a Finnish liverwort’.
Occasionally, though, the added value
of particularly desirable units tempts
laboratories to engage in direct
competition. This is usually dealt
with by the formation of a collusive
agreement, called a collaboration, or,
sometimes, the academic equivalent
of guerrilla warfare.
The new players in the knowledge
industry produce lots of units of
knowledge as cheaply as possible
In the past decade, however, there
have been new entrants to the
knowledge industry who use a
completely different strategy. Rather
than producing a few differentiated
units for a specific niche in the
market, these players aim to produce
large volumes as cheaply as possible.
The mind-bogglingly large number of
repetitive tasks required is performed
by robots rather than by postdocs.
What they produce are seldom fully
finished units of knowledge but the
intermediate products, namely data
and information. To gain as much
value as possible from this semi-
processed knowledge, these players
hire lawyers to convince patent offices
that their data or information
constitute an invention.
One of the characteristics of this
approach, commonly described as
‘factory’ science, is that it tends to
generate answers in search of
questions rather than the other way
around. Thus, when the appropriate
question is eventually identified, the
intellectual property rights for the
knowledge have already been secured
by one of the factory producers.
Not only has the internal
structure of the knowledge industry
changed, but the dynamics of
knowledge production have also
altered. As is the case for every field
in science, the limitations of
biological research are limitations of
technology and imagination. In the
past decade, the technology available
for biological research has improved
enormously. The results of
experiments that were once
considered almost impossible are
now walking around the Scottish
Highlands eating grass.
The downside is that this new
technology is often very expensive
and complicated to develop. This has
led to a new approach to data
production, namely outsourcing.
With a little imagination and a bit of
cash, scientists can obtain all the data
they require to produce their
knowledge units without ever having
to touch a micropipette.
But even this can make the
production costs for a unit of
knowledge too high for the traditional
laboratory. Fortunately, there are new
buyers who can provide the cash
needed for access to this new
technology: the biotechnology and
pharmaceutical companies. These
buyers will often prepurchase units
by forming strategic alliances or offer
magnificent facilities for the in-house
production of knowledge units. The
compromise, however, is that the new
units must have the potential to
generate sales revenue. Thus, to woo
these buyers it is necessary to
package your units using the correct
business-speak, and to own a jacket
that does not have suede elbow
patches. Failure to take these 
steps will limit your sales to the
traditional buyers.
So, the next time your paper is
bounced from a journal or your
grant proposal is underfunded,
remind yourself that there are other
buyers for your products. It might
be time to buy a business suit and
follow the money.
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